Literature DB >> 17095259

Increased CK19 expression correlated with pathologic differentiation grade and prognosis in oral squamous cell carcinoma patients.

Lai-ping Zhong1, Wan-tao Chen, Chen-ping Zhang, Zhi-yuan Zhang.   

Abstract

OBJECTIVE: To investigate cytokeratin 19 (CK19) expression in oral squamous cell carcinoma (OSCC) tissue as well as its correlation with pathologic differentiation grade and prognosis. STUDY
DESIGN: Cancerous and distant tissues from 33 primary OSCC patients were collected during surgery. Each sample was divided into 2 parts, one for CK19 protein detection using immunohistochemistry, and the other for CK19 mRNA-level detection of relative quantification using fluorescent real-time reverse transcriptase polymerase chain reaction (RT-PCR).
RESULTS: The CK19 positive rate in cancerous tissue was 90.9% (30 out of 33) detected using immunohistochemistry, which was significantly higher than that in distant tissue (15.2%, 5 out of 33) by chi-square test (P < .001). The CK19 positive score in cancerous tissue was also significantly higher than that in the corresponding distant tissue by paired samples t test (P < .001). Patients with positive CK19 expression in distant tissue had higher tumor recurrence rate (P = .008) and lower survival rate (P = .015) than those with negative CK19 expression in distant tissue. Using fluorescent real-time RT-PCR, CK19 mRNA level in cancerous tissue was 2.21-fold higher than that in distant tissue (P = .020). The CK19 expression correlated significantly with pathologic differentiation grade, which was detected not only using immunohistochemistry (P = .002) but also using fluorescent real-time RT-PCR (P = .025), poorer differentiated indicating higher CK19 positive score and CK19 mRNA level.
CONCLUSIONS: Increased CK19 protein expression and gene transcription in OSCC tissue correlate significantly with pathologic differentiation grade. Positive CK19 expression in distant tissue suggests a higher tumor recurrence rate and a lower survival rate.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17095259     DOI: 10.1016/j.tripleo.2006.07.019

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  18 in total

1.  Analysis of immunohistochemical expression of k19 in oral epithelial dysplasia and oral squamous cell carcinoma using color deconvolution-image analysis method.

Authors:  Rima A Safadi; Atika S Musleh; Taiseer H Al-Khateeb; Abed Al-Hadi Hamasha
Journal:  Head Neck Pathol       Date:  2010-09-30

2.  Overexpression of Galectin-1 is negatively correlated with pathologic differentiation grade in oral squamous cell carcinoma.

Authors:  Lai-ping Zhong; Kui-jie Wei; Xiao Yang; Hong-ya Pan; Dong-xia Ye; Li-zhen Wang; Zhi-yuan Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-16       Impact factor: 4.553

3.  Oral dysplasia and squamous cell carcinoma: correlation between increased expression of CD21, Epstein-Barr virus and CK19.

Authors:  Ru Jiang; Xin Gu; Tara N Moore-Medlin; Cherie-Ann Nathan; Lindsey M Hutt-Fletcher
Journal:  Oral Oncol       Date:  2012-04-16       Impact factor: 5.337

4.  Clinical meaning of age-related expression of fecal cytokeratin 19 in colorectal malignancy.

Authors:  Chun-Chao Chang; Shung-Haur Yang; Chih-Cheng Chien; Shu-Hung Chen; Shiann Pan; Chia-Long Lee; Chih-Ming Lin; Hsiao-Lun Sun; Chi-Cheng Huang; Yih-Yiing Wu; Ruey-Neng Yang; Chi-Jung Huang
Journal:  BMC Cancer       Date:  2009-10-22       Impact factor: 4.430

5.  Quantitative proteomics reveals myosin and actin as promising saliva biomarkers for distinguishing pre-malignant and malignant oral lesions.

Authors:  Ebbing P de Jong; Hongwei Xie; Getiria Onsongo; Matthew D Stone; Xiao-Bing Chen; Joel A Kooren; Eric W Refsland; Robert J Griffin; Frank G Ondrey; Baolin Wu; Chap T Le; Nelson L Rhodus; John V Carlis; Timothy J Griffin
Journal:  PLoS One       Date:  2010-06-17       Impact factor: 3.240

6.  Changes in oral cytokeratin expression in HIV-infected subjects with long-term use of HAART.

Authors:  W Nittayananta; W Mitarnun; S Talungchit; H Sriplung
Journal:  Oral Dis       Date:  2012-07-02       Impact factor: 3.511

7.  Expressional analysis of p16 and cytokeratin19 protein in the genesis of oral squamous cell carcinoma patients.

Authors:  Ali Yousif Babiker; Arshad H Rahmani; Mohamed S Abdalaziz; Aqel Albutti; Salah M Aly; Hussain Gadelkareem Ahmed
Journal:  Int J Clin Exp Med       Date:  2014-06-15

8.  Cytokeratin 17 mRNA expression has potential for diagnostic marker of oral squamous cell carcinoma.

Authors:  Takeshi Toyoshima; Eleftherios Vairaktaris; Emeka Nkenke; Karl Andreas Schlegel; Friedrich Wilhelm Neukam; Jutta Ries
Journal:  J Cancer Res Clin Oncol       Date:  2007-09-04       Impact factor: 4.553

9.  Immunoexpression of cytokeratin-19 in the oral lichen planus and related oral squamous cell carcinoma.

Authors:  Gian Paolo Bombeccari; Aldo Bruno Giannì; Francesco Spadari
Journal:  Ann Stomatol (Roma)       Date:  2018-03-08

10.  PROX1 gene is differentially expressed in oral cancer and reduces cellular proliferation.

Authors:  Maria F S D Rodrigues; Camila de Oliveira Rodini; Flávia C de Aquino Xavier; Katiúcia B Paiva; Patrícia Severino; Raquel A Moyses; Rossana M López; Rafael DeCicco; Lília A Rocha; Marcos B Carvalho; Eloiza H Tajara; Fabio D Nunes
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.